ABVD or BEACOPP(baseline) along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Etude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial

C Ferme, J Thomas, P Brice, O Casasnovas, A Vranovsky, S Bologna, Elly Lugtenburg, R Bouabdallah, P Carde, C Sebban, H Eghbali, G Salles, GW van Imhoff, A Thyss, EM Noordijk, O Reman, MLM Lybeert, M Janvier, M Spina, B AudhuyJMM Raemaekers, R Delarue, B Anglaret, O de Weerdt, Z Marjanovic, R Tersteeg, D de Jong, J Briere, M Henry-Amar

Research output: Contribution to journalArticleAcademicpeer-review

31 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)45-55
Number of pages11
JournalEuropean Journal of Cancer
Publication statusPublished - 2017

Research programs

  • EMC OR-01

Cite this